Stereotaxis Stock
Your prediction
Stereotaxis Stock
There is an upward development for Stereotaxis compared to yesterday, with an increase of €0.022 (1.900%).
Pros and Cons of Stereotaxis in the next few years
Pros
?
S********** s********
?
M***** P*******
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Stereotaxis vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Stereotaxis | 1.900% | -9.176% | -20.109% | -45.421% | -40.408% | -12.180% | -85.308% |
| Cardiff Oncology Inc. | -4.620% | -5.968% | -36.470% | -75.552% | -71.753% | -46.043% | -84.174% |
| Electrocore Inc. | 2.940% | -3.774% | -26.087% | -12.821% | 33.508% | 39.097% | -60.145% |
| Lightpath Techs A | 8.540% | -17.890% | -37.413% | - | 0.000% | - | - |
News
Stereotaxis Q1 Earnings Call Highlights
Stereotaxis (NYSEAMERICAN:STXS) said its first-quarter results did not yet reflect what management described as a major commercial transition
